Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorNIANGORAN, Serge
hal.structure.identifierBordeaux population health [BPH]
hal.structure.identifierGlobal Health in the Global South [GHiGS]
dc.contributor.authorJOURNOT, Valerie
hal.structure.identifierBordeaux population health [BPH]
hal.structure.identifierGlobal Health in the Global South [GHiGS]
dc.contributor.authorMARCY, Olivier
hal.structure.identifierBordeaux population health [BPH]
hal.structure.identifierGlobal Health in the Global South [GHiGS]
dc.contributor.authorANGLARET, Xavier
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorALIOUM, Amadou
dc.date.accessioned2023-10-04T13:52:23Z
dc.date.available2023-10-04T13:52:23Z
dc.date.issued2023-08-01
dc.identifier.issn2451-8654en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/184321
dc.description.abstractEnEnsuring the quality of data is essential for the credibility of a multicenter clinical trial. Centralized Statistical Monitoring (CSM) of data allows the detection of a center in which the distribution of a specific variable is atypical compared to other centers. The ideal CSM method should allow early detection of problem and therefore involve the fewest possible participants. We simulated clinical trials and compared the performance of four CSM methods (Student, Hatayama, Desmet, Distance) to detect whether the distribution of a quantitative variable was atypical in one center in relation to the others, with different numbers of participants and different mean deviation amplitudes. The Student and Hatayama methods had good sensitivity but poor specificity, which disqualifies them for practical use in CSM. The Desmet and Distance methods had very high specificity for detecting all the mean deviations tested (including small values) but low sensitivity with mean deviations less than 50%. Although the Student and Hatayama methods are more sensitive, their low specificity would lead to too many alerts being triggered, which would result in additional unnecessary control work to ensure data quality. The Desmet and Distance methods have low sensitivity when the deviation from the mean is low, suggesting that the CSM should be used alongside other conventional monitoring procedures rather than replacing them. However, they have excellent specificity, which suggests they can be applied routinely, since using them takes up no time at central level and does not cause any unnecessary workload in investigating centers.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subject.enCentralized Statistical monitoring
dc.subject.enData quality
dc.subject.enMulticenter clinical trial
dc.subject.enSensitivity
dc.subject.enSpecificity
dc.title.enPerformance of four centralized statistical monitoring methods for early detection of an atypical center in a multicenter study.
dc.title.alternativeContemp Clin Trials Communen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.conctc.2023.101168en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed37425338en_US
bordeaux.journalContemporary Clinical Trials Communicationsen_US
bordeaux.page101168en_US
bordeaux.volume34en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamGHIGSen_US
bordeaux.teamBIOSTATen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDInstitut de Recherche pour le Développementen_US
bordeaux.import.sourcepubmed
hal.identifierhal-04228569
hal.version1
hal.date.transferred2023-10-04T13:52:26Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Contemporary%20Clinical%20Trials%20Communications&rft.date=2023-08-01&rft.volume=34&rft.spage=101168&rft.epage=101168&rft.eissn=2451-8654&rft.issn=2451-8654&rft.au=NIANGORAN,%20Serge&JOURNOT,%20Valerie&MARCY,%20Olivier&ANGLARET,%20Xavier&ALIOUM,%20Amadou&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée